Texas Statutes
Subchapter A. Prescription and Substitution Requirements
Section 562.008. Generic Equivalent or Interchangeable Biological Product Authorized

Sec. 562.008. GENERIC EQUIVALENT OR INTERCHANGEABLE BIOLOGICAL PRODUCT AUTHORIZED. (a) If a practitioner certifies on the prescription form that a specific prescribed brand is medically necessary, the pharmacist shall dispense the drug or biological product as written by the practitioner. The certification must be made as required by the dispensing directive adopted under Section 562.015. This subchapter does not permit a pharmacist to substitute a generically equivalent drug or interchangeable biological product unless the substitution is made as provided by this subchapter.
(b) Except as otherwise provided by this subchapter, a pharmacist who receives a prescription for a drug or biological product for which there is one or more generic equivalents or one or more interchangeable biological products may dispense any of the generic equivalents or interchangeable biological products.
Acts 1999, 76th Leg., ch. 388, Sec. 1, eff. Sept. 1, 1999. Amended by Acts 2001, 77th Leg., ch. 1254, Sec. 6, eff. Sept. 1, 2001.
Amended by:
Acts 2015, 84th Leg., R.S., Ch. 1007 (H.B. 751), Sec. 7, eff. September 1, 2015.

Structure Texas Statutes

Texas Statutes

Occupations Code

Title 3 - Health Professions

Subtitle J - Pharmacy and Pharmacists

Chapter 562 - Practice by License Holder

Subchapter A. Prescription and Substitution Requirements

Section 562.001. Definitions

Section 562.002. Legislative Intent

Section 562.003. Disclosure of Price; Patient's Option

Section 562.004. Prescription Transmitted Orally by Practitioner

Section 562.005. Record of Dispensed Drug or Biological Product

Section 562.0051. Communication Regarding Certain Dispensed Biological Products

Section 562.006. Label

Section 562.0061. Other Prescription Information

Section 562.0062. Required Statement Regarding Medication Disposal

Section 562.007. Refills

Section 562.008. Generic Equivalent or Interchangeable Biological Product Authorized

Section 562.009. Requirements Concerning Selection of Generically Equivalent Drug or Interchangeable Biological Product

Section 562.010. Responsibility Concerning Generically Equivalent Drug or Interchangeable Biological Product; Liability

Section 562.011. Restriction on Selection of and Charging for Generically Equivalent Drug or Interchangeable Biological Product

Section 562.012. Substitution of Dosage Form Permitted

Section 562.013. Applicability of Subchapter

Section 562.014. Narrow Therapeutic Index Drugs

Section 562.0141. Transplant Immunosuppressant Drug Product Selection Prohibited

Section 562.0142. Adoption of Rules

Section 562.015. Dispensing Directive; Compliance With Federal Law

Section 562.016. List of Approved Interchangeable Biological Products